Heart Rate Variability Recording With Elite HRV Application and Polar V800
Launched by UNIVERSITY OF SAO PAULO · Dec 2, 2022
Trial Information
Current as of February 05, 2025
Unknown status
Keywords
ClinConnect Summary
Sample Characterization Before starting the evaluation, an anamnesis will apply, in order to know the individual characteristics of each candidate and verify if he eligible. In addition, anthropometric variables such as weight, height and Body Mass Index will perform to characterize the individuals.
Heart Rate Variability (HRV) Heart rate will recorded beat by beat using a heart rate meter (Polar H10, Polar Electro, Kempele, Finland) at a sampling rate of 5 kHz to assess cardiac autonomic modulation.
With the chest strap and the receiving and recording device (Elite HRV and Polar V800), t...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals over 18 years of age
- • Apparently healthy
- Exclusion Criteria:
- • Diagnoses of previously installed heart disease
- • Continuous medication use that can alter HRV
- • Use of any substance that could influence the autonomic nervous system, such as caffeinated drinks and foods.
Trial Officials
Talita D da Silva
Principal Investigator
Researcher
About University Of Sao Paulo
The University of São Paulo (USP) is a prestigious public research university located in Brazil, renowned for its commitment to advancing knowledge and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, USP leverages its extensive academic resources, interdisciplinary expertise, and state-of-the-art facilities to facilitate groundbreaking research aimed at improving patient outcomes and addressing critical health challenges. The university's strong emphasis on ethical standards and regulatory compliance ensures that all clinical trials are conducted with the highest integrity, fostering collaboration among researchers, healthcare professionals, and the broader community to enhance scientific discovery and translate findings into practical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
São Paulo, Sp, Brazil
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials